相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Revolution dawning in cardiotoxicity testing
Kelly Rae Chi
NATURE REVIEWS DRUG DISCOVERY (2013)
Refining the Human iPSC-Cardiomyocyte Arrhythmic Risk Assessment Model
Liang Guo et al.
TOXICOLOGICAL SCIENCES (2013)
Phenotypic Profiling of Structural Cardiotoxins In Vitro Reveals Dependency on Multiple Mechanisms of Toxicity
Amy Pointon et al.
TOXICOLOGICAL SCIENCES (2013)
Comparison of Electrophysiological Data From Human-Induced Pluripotent Stem CellDerived Cardiomyocytes to Functional Preclinical Safety Assays
Kate Harris et al.
TOXICOLOGICAL SCIENCES (2013)
Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes
Kimberly R. Doherty et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Human induced pluripotent stem cells and their use in drug discovery for toxicity testing
Clay W. Scott et al.
TOXICOLOGY LETTERS (2013)
MICE Models: Superior to the HERG Model in Predicting Torsade de Pointes
James Kramer et al.
SCIENTIFIC REPORTS (2013)
Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay
Yusheng Qu et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2013)
Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment
Yama A. Abassi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Differentiating electrophysiological effects and cardiac safety of drugs based on the electrocardiogram: A blinded validation
Tengxian Liu et al.
HEART RHYTHM (2012)
Characterization of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Bioenergetics and Utilization in Safety Screening
Payal Rana et al.
TOXICOLOGICAL SCIENCES (2012)
High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents
Junyi Ma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Developmental toxicity testing in the 21st century: the sword of Damocles shattered by embryonic stem cell assays?
Andrea Seiler et al.
ARCHIVES OF TOXICOLOGY (2011)
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk
Gary R. Mirams et al.
CARDIOVASCULAR RESEARCH (2011)
The Electrophysiological Effects of Cardiac Glycosides in Human iPSC-derived Cardiomyocytes and in Guinea Pig Isolated Hearts
Liang Guo et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2011)
Electrophysiological Characterization of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Masaki Honda et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2011)
An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation
Gary Gintant
PHARMACOLOGY & THERAPEUTICS (2011)
Estimating the Risk of Drug-Induced Proarrhythmia Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Liang Guo et al.
TOXICOLOGICAL SCIENCES (2011)
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes
Stefan R. Braam et al.
STEM CELL RESEARCH (2010)
Combination of Functional Cardiomyocytes Derived from Human Stem Cells and a Highly-Efficient Microelectrode Array System: An Ideal Hybrid Model Assay for Drug Development
Yasuyuki Asai et al.
CURRENT STEM CELL RESEARCH & THERAPY (2010)
The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes
Shengde Peng et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2010)
High-Content Screening: A Decade of Evolution
Nick Thomas
JOURNAL OF BIOMOLECULAR SCREENING (2010)
In Vitro Electrophysiological Drug Testing Using Human Embryonic Stem Cell Derived Cardiomyocytes
Oren Caspi et al.
STEM CELLS AND DEVELOPMENT (2009)
In vitro preclinical cardiac assessment of tolterodine and terodiline: Multiple factors predict the clinical experience
Ruth L. Martin et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Utility of hERG assays as surrogate markers of delayed cardiac repolarization and QT safety
GA Gintant et al.
TOXICOLOGIC PATHOLOGY (2006)
Micro-electrode arrays in cardiac safety pharmacology - A novel tool to study QT interval prolongation
T Meyer et al.
DRUG SAFETY (2004)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
WS Redfern et al.
CARDIOVASCULAR RESEARCH (2003)
Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures
MD Halbach et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2003)
分享论文
